| Financial Year |
March 31 2023 |
| Monetary Funds |
857,765,091.35 |
| Held-for-trading Financial Assets |
39,241,113.81 |
| Notes Receivable |
-- |
| Accounts Receivable |
32,529,687.06 |
| Advances to Suppliers |
218,925,650.66 |
| Other Receivables |
339,199,055.33 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,815,892,643.15 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
108,115,583.66 |
| Total Current Assets |
4,411,668,825.02 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
488,710,802.03 |
| Investment Properties |
246,587,698.55 |
| Fixed Assetes |
11,976,053,558.78 |
| Under-construction Projects |
783,302,121.54 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,551,882,210.22 |
| R&D expenses |
-- |
| Goodwill |
77,499,623.55 |
| Long-Term Deferred and Prepaid Expenses |
259,232,154.84 |
| Deferred Income Tax Assets |
453,880,558.51 |
| Other Non-Current Assets |
184,854,023.05 |
| Sub-Total of Non-Current Assets |
17,162,516,038.79 |
| Total Assets |
21,574,184,863.81 |
| Short-Term Loans |
6,173,900,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,080,870,000.00 |
| Accounts Payable |
1,729,881,389.46 |
| Accounts Received In Advance |
117,716,807.37 |
| Employee Compensation Payable |
25,779,314.28 |
| Taxes Payable |
76,746,567.94 |
| Interest Payable |
-- |
| Dividend Payable |
18,023,742.67 |
| Other payables |
2,032,290,914.78 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
824,156,962.74 |
| Other Current Liabilities |
330,654,267.83 |
| Sub-Total of Current Liabilities |
15,109,878,972.93 |
| Long-term Loans |
1,367,958,882.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
4,874,715.29 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
364,825,628.61 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,066,720,717.91 |
| Total Liabilities |
17,176,599,690.84 |
| Paid-In Capital(Or Share Stock) |
159,088,075.00 |
| Capital Surplus |
408,466,144.61 |
| Surplus Reserve |
79,544,037.50 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,744,424,232.29 |
| Minority Stockholder's Interest |
2,004,096,279.99 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,393,488,892.98 |
| Owner's Equity（Stockholder's Equity） |
4,397,585,172.97 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
21,574,184,863.81 |
